Bayesian Capital Management’s AB InBev BUD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,700
Closed -$1.52M 569
2025
Q1
$1.52M Buy
24,700
+16,100
+187% +$881K 0.25% 116
2024
Q4
$431K Sell
8,600
-4,800
-36% -$278K 0.05% 400
2024
Q3
$888K Sell
13,400
-26,000
-66% -$1.6M 0.1% 265
2024
Q2
$2.29M Buy
+39,400
New +$2.41M 0.26% 97
2024
Q1
Sell
-8,825
Closed -$570K 801
2023
Q4
$570K Sell
8,825
-12,019
-58% -$710K 0.06% 354
2023
Q3
$1.15M Sell
20,844
-24,900
-54% -$1.41M 0.13% 190
2023
Q2
$2.59M Buy
+45,744
New +$2.77M 0.28% 87
2023
Q1
Sell
-31,901
Closed -$1.92M 802
2022
Q4
$1.92M Buy
31,901
+19,700
+161% +$1.06M 0.28% 66
2022
Q3
$551K Sell
12,201
-10,999
-47% -$570K 0.11% 256
2022
Q2
$1.25M Buy
+23,200
New +$1.3M 0.23% 114
2022
Q1
Sell
-54,177
Closed -$3.28M 785
2021
Q4
$3.28M Buy
54,177
+45,700
+539% +$2.66M 1.04% 18
2021
Q3
$478K Buy
+8,477
New +$532K 0.14% 193
2021
Q2
Sell
-13,960
Closed -$877K 433
2021
Q1
$877K Buy
13,960
+5,000
+56% +$323K 0.2% 136
2020
Q4
$626K Buy
+8,960
New +$567K 0.16% 176
2019
Q4
Sell
-5,900
Closed -$561K 600
2019
Q3
$561K Sell
5,900
-4,700
-44% -$446K 0.11% 253
2019
Q2
$938K Buy
+10,600
New +$909K 0.19% 152
2018
Q4
Sell
-3,600
Closed -$315K 619
2018
Q3
$315K Sell
3,600
-12,900
-78% -$1.26M 0.05% 443
2018
Q2
$1.66M Buy
16,500
+1,700
+11% +$169K 0.37% 65
2018
Q1
$1.63M Buy
+14,800
New +$1.64M 0.41% 43
2017
Q4
Sell
-13,900
Closed -$1.66M 559
2017
Q3
$1.66M Sell
13,900
-7,500
-35% -$878K 0.4% 64
2017
Q2
$2.36M Buy
+21,400
New +$2.45M 0.87% 7

Other funds holding BUD

Bayesian Capital Management's BUD Position: Q2 2025 in Review

Bayesian Capital Management sold out of AB InBev (BUD) in Q2 2025, closing a stake of 24,700 shares — an estimated $1.52M sold.

Bayesian Capital Management first reported a position in BUD in Q2 2017 and held it in 21 quarters. The position peaked at $3.28M in Q4 2021. 512 funds tracked by Wall St. Rank hold BUD as of Q2 2025.

  • Bayesian Capital Management reported no remaining AB InBev position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 24,700 AB InBev shares in Q2 2025, an estimated $1.52M.
  • Bayesian Capital Management first reported a position in AB InBev in Q2 2017 and held it in 21 quarters.
  • Bayesian Capital Management's AB InBev position peaked at $3.28M in Q4 2021.
  • 512 funds tracked by Wall St. Rank held AB InBev as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.